Possible mechanisms lead to primary resistance in first-generation EGFR-TKIs include PIK3CA mutations, MET amplification, BIM polymorphism, changes in the PIK3CA-AKT-mTOR signaling pathway, and the transformation from NSCLC to small cell lung cancer. The gene discussed is PIK3CA; the disease is non-small cell lung carcinoma.